Acrivastine and pseudoephedrine and Noxafil (Posaconazole Delayed-Release Tablets)
Determining the interaction of Acrivastine and pseudoephedrine and Noxafil (Posaconazole Delayed-Release Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Noxafil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Noxafil (Posaconazole Injection)
- Acrivastine and pseudoephedrine-Noxafil (Posaconazole Oral Suspension)
- Acrivastine and pseudoephedrine-Noxafil Intravenous
- Acrivastine and pseudoephedrine-Noxifol-D
- Acrivastine and pseudoephedrine-Noxivent
- Acrivastine and pseudoephedrine-NP Thyroid
- Noxafil (Posaconazole Delayed-Release Tablets)-Actamin
- Noxafil (Posaconazole Delayed-Release Tablets)-Actamin Maximum Strength
- Noxafil (Posaconazole Delayed-Release Tablets)-Actemra
- Noxafil (Posaconazole Delayed-Release Tablets)-Actemra (Tocilizumab (Intravenous))
- Noxafil (Posaconazole Delayed-Release Tablets)-Actemra (Tocilizumab Auto-Injectors)
- Noxafil (Posaconazole Delayed-Release Tablets)-Actemra (Tocilizumab Prefilled Syringes)